BlackRock’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-84
Closed -$62 5318
2023
Q4
$62 Sell
84
-356
-81% -$263 ﹤0.01% 5264
2023
Q3
$383 Sell
440
-24
-5% -$21 ﹤0.01% 5293
2023
Q2
$868 Sell
464
-3,355
-88% -$6.28K ﹤0.01% 5325
2023
Q1
$14.1K Buy
3,819
+101
+3% +$374 ﹤0.01% 5205
2022
Q4
$14.1K Buy
3,718
+62
+2% +$236 ﹤0.01% 5335
2022
Q3
$29K Sell
3,656
-104
-3% -$825 ﹤0.01% 5367
2022
Q2
$80K Sell
3,760
-11
-0.3% -$234 ﹤0.01% 5210
2022
Q1
$141K Sell
3,771
-155
-4% -$5.8K ﹤0.01% 5113
2021
Q4
$220K Sell
3,926
-160
-4% -$8.97K ﹤0.01% 5014
2021
Q3
$295K Sell
4,086
-262
-6% -$18.9K ﹤0.01% 4823
2021
Q2
$416K Sell
4,348
-42,122
-91% -$4.03M ﹤0.01% 4667
2021
Q1
$6.87M Buy
46,470
+8
+0% +$1.18K ﹤0.01% 3731
2020
Q4
$6.5M Buy
46,462
+1,147
+3% +$160K ﹤0.01% 3513
2020
Q3
$6.88M Sell
45,315
-1,318
-3% -$200K ﹤0.01% 3344
2020
Q2
$8.19M Buy
46,633
+44,030
+1,692% +$7.73M ﹤0.01% 3232
2020
Q1
$371K Hold
2,603
﹤0.01% 4043
2019
Q4
$375K Buy
2,603
+1,565
+151% +$225K ﹤0.01% 4149
2019
Q3
$104K Hold
1,038
﹤0.01% 4384
2019
Q2
$71K Hold
1,038
﹤0.01% 4483
2019
Q1
$47K Buy
1,038
+1
+0.1% +$45 ﹤0.01% 4436
2018
Q4
$35K Buy
1,037
+4
+0.4% +$135 ﹤0.01% 4475
2018
Q3
$77K Buy
1,033
+1
+0.1% +$75 ﹤0.01% 4427
2018
Q2
$81K Buy
1,032
+3
+0.3% +$235 ﹤0.01% 4438
2018
Q1
$91K Sell
1,029
-18
-2% -$1.59K ﹤0.01% 4306
2017
Q4
$779K Buy
1,047
+2
+0.2% +$1.49K ﹤0.01% 3913
2017
Q3
$301K Buy
1,045
+3
+0.3% +$864 ﹤0.01% 4081
2017
Q2
$267K Sell
1,042
-264
-20% -$67.6K ﹤0.01% 4124
2017
Q1
$435K Buy
+1,306
New +$435K ﹤0.01% 3955